One of my investing mentors is one of the most interesting people I’ve ever met.
In a former life, she had a front-row seat at the professional poker circuit. Remember when you began to see it on TV about 20 years ago? I remember in college, I had friends who would stay up at night watching guys like Phil Hellmeuth and Doyle Brunson play Texas Hold ‘Em like they would any other mainstream sport. And in between classes, they’d log on to their computers and play against other people around the world — hoping to score enough to buy a keg, pay for books, or even take a trip for spring break.
Anyway, my investing mentor was right there for it all. She knew a lot of these guys personally, and had had enough juice in these circles to be able to hold her own across the table from Texas billionaire businessmen and guys with multiple World Series of Poker Championship bracelets.
Now, you might think it strange that a person like this would be an investing mentor for me. But she knows her stuff. In fact, she told me one of the most valuable lessons I’ll never forget. She said, whether it came to poker or investing, “You have to have enough chips to stay in the game.”
Hot Heal Care Stocks To Invest In Right Now: Trevena, Inc.(TRVN)
Trevena, Inc. is a clinical stage biopharmaceutical company that discovers, develops and intends to commercialize therapeutics that use a novel approach to target G protein coupled receptors, or GPCRs. Unless the context otherwise requires, we use the terms “Trevena,” “company,” “we,” “us” and “our” to refer to Trevena, Inc.
Using our proprietary product platform, we have identified and are developing the following three differentiated product candidates:
潞 * 潞 Oliceridine (TRV130): We are developing oliceridine as a first-line treatment for patients experiencing moderate to severe acute pain where IV administration is preferred. Advisors’ Opinion:
- [By Money Morning News Team]
The third-highest penny stock performer was also in healthcare. It was Trevena Inc. (NASDAQ: TRVN), which rose nearly 87% to stand at $1.01. The fourth penny stock to watch this week is another healthcare stock, Celldex Therapeutics (NASDAQ: CLDX), which climbed nearly 67% to close at $0.58.
- [By Money Morning Staff Reports]
Before we get to our latest pick, here are last week’s top-performing penny stocks:
Penny Stock Sector Current Share Price Last Week’s Gain
Melinta Therapeutics Inc. (NASDAQ: MLNT) Healthcare $1.74 104.01%
Pernix Therapeutics Holdings Inc. (NASDAQ: PTX) Healthcare $0.83 84.40%
Top Image Systems Ltd. (NASDAQ: TISA) Healthcare $0.82 59.85%
Jason Industries Inc. (NASDAQ: JASN) Healthcare $2.21 58.99%
Maxwell Technologies Inc. (NASDAQ: MXWL) Financial $4.66 51.79%
Marathon Patent Group Inc. (NASDAQ: MARA) Healthcare $0.52 51.47%
Forward Pharma A/S (NASDAQ: FWP) Basic Materials $1.53 43.57%
Dixie Group Inc. (NASDAQ: DXYN) Healthcare $1.40 42.86%
Trevena Inc. (NASDAQ: TRVN) Services $1.41 39.60%
Alliance MMA Inc. (NASDAQ: AMMA) Healthcare $4.95 36.18%
Don’t Miss Out: The Treasury is sitting on an $11.1 billion cash pile, and a loophole entitles Americans to a sizable portion. Some are collecting $1,795, $3,000, or $5,000 every month thanks to this powerful investment…
- [By Stephan Byrd]
ILLEGAL ACTIVITY WARNING: “Insider Buying: Trevena Inc (TRVN) CEO Purchases 50,000 Shares of Stock” was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at www.tickerreport.com/banking-finance/4136441/insider-buying-trevena-inc-trvn-ceo-purchases-50000-shares-of-stock.html.
- [By Money Morning Staff Reports]
Here are last week’s top-performing penny stocks:
Penny Stock Sector Current Share Price Last Week’s Gain
OncoCyte Corp. (NYSE: OCX) Healthcare $4.98 159.38%
Fortress Biotech (NASDAQ: FBIO) Healthcare $2.47 133.02%
Trevena Inc. (NASDAQ: TRVN) Healthcare $1.01 86.69%
Celldex Therapeutics Inc. (NASDAQ: CLDX) Healthcare $0.58 66.82%
Wheeler Real Estate Investment Trust Inc.(NASDAQ: WHLR) Financial $1.80 63.64%
Scynexis Inc. (NASDAQ: SCYX) Healthcare $1.13 53.64%
Eldorado Gold Corp. (NYSE: EGO) Basic Materials $3.98 47.96%
Novus Therapeutics Inc. (NASDAQ: NVUS) Healthcare $4.15 43.60%
PHI Inc. (NASDAQ: PHII) Services $4.50 42.14%
BioTime Inc. (NYSE: BTX) Healthcare $1.33 41.50%
See Now: Our founder just released his No. 1 pick for 2019. Don’t miss this. See urgent briefing here…
Hot Heal Care Stocks To Invest In Right Now: Freeport-McMoran, Inc.(FCX)
Freeport-McMoRan Inc. (FCX), incorporated on November 10, 1987, is a natural resource company with a portfolio of mineral assets, and oil and natural gas resources. The Company’s segments include the Morenci, Cerro Verde, Grasberg and Tenke Fungurume copper mines, the Rod & Refining operations and the U.S. Oil & Gas Operations. FCX has organized its operations into five primary divisions: North America copper mines, South America mining, Indonesia mining, Africa mining and Molybdenum mines. The Company’s portfolio of assets includes the Grasberg minerals district in Indonesia, mining operations in North and South America, the Tenke Fungurume (Tenke) minerals district in the Democratic Republic of Congo (DRC) in Africa, and oil and natural gas assets in the United States.
The Company’s Atlantic Copper unit in Spain smelts and refines copper concentrates, and markets refined copper and precious metals in slimes. The Company has a smelter at its Miami, Arizona, mining operation; a cobalt chemical refinery in Kokkola, Finland; molybdenum conversion facilities in the United States and Europe; over four non-operating copper mines in North America (Ajo, Bisbee and Tohono in Arizona and Cobre in New Mexico), and other mining support entities.
North America Copper Mines
FCX has over seven operating copper mines in North America, including Morenci, Bagdad, Safford, Sierrita and Miami in Arizona, and Tyrone and Chino in New Mexico. The North America copper mines include open-pit mining, sulfide ore concentrating, leaching and solution extraction/electrowinning (SX/EW) operations. The copper produced at the North America copper mines is cast into copper rods by its Rod & Refining operations. In addition to copper, the Company’s North America copper mines also produce molybdenum concentrates and silver. The Morenci open-pit mine, located in southeastern Arizona, produces copper cathodes and copper concentrate. In addition to copper, the Morenci mine also produces molybdenum c! oncentrate.
South America Mining
South America mining includes over two operating copper mines: Cerro Verde in Peru and El Abra in Chile. These operations include open-pit mining, sulfide ore concentrating, leaching and SX/EW operations. The Cerro Verde open-pit copper mine, located near Arequipa, Peru, produces copper cathodes and copper concentrates. In addition to copper, the Cerro Verde mine also produces molybdenum concentrate and silver.
Indonesia mining includes PT Freeport Indonesia’s Grasberg minerals district. It produces copper concentrates, which contain quantities of gold and silver.
Africa mining includes the Tenke minerals district. The Tenke operation includes surface mining, leaching and SX/EW operations and produces copper cathode. In addition to copper, the Tenke operation produces cobalt hydroxide.
Molybdenum mines include the Henderson underground mine and Climax open-pit mine in Colorado. The Henderson and Climax mines produce chemical-grade molybdenum concentrates, which are processed into molybdenum chemical products.
Rod & Refining
The Rod & Refining segment consists of copper conversion facilities located in North America, and includes a refinery, over three rod mills and a copper products facility. These operations process copper produced at its North America copper mines and purchased copper into copper cathode, rod and custom copper shapes. These operations also refine copper and produce copper rod and shapes for customers on a toll basis.
United States Oil and Gas Operations
Its U.S. Oil & Gas Operations include oil and natural gas assets in the Deepwater Gulf of Mexico (GOM), onshore and offshore California, the Haynesville shale in Louisiana, the Madden area in central Wyoming and a position in the Inboard Lower Tertiary/Cretaceous natural gas trend onshore in South Louis! iana.
- [By ]
However, Cleveland-Cliffs shares on Monday fell 1.9% to $25.36 at last check along with U.S. Steel (X) – Get Report, Nucor (NUE) – Get Report, and Freeport-McMoran (FCX) – Get Report.
- [By Reuben Gregg Brewer]
The shares of Freeport-McMoRan Inc. (NYSE:FCX) rose a solid 10.8% in February according to data provided by S&P Global Market Intelligence. Add that monthly advance to the January rally, and Freeport-McMoRan was up a hefty 25% or so in the first two months of 2019. There were a couple of reasons for this strong early-year showing.
Hot Heal Care Stocks To Invest In Right Now: GXO Logistics, Inc.(GXO)
GXO Logistics, Inc. provides supply chain management solutions for multinational companies and blue-chip market leaders worldwide. It serves consumer packaged goods, ecommerce, food and beverage, retail, technology, and consume electronic industries. The company was incorporated in 2021 and is based in Greenwich, Connecticut. GXO Logistics, Inc. operates independently of XPO Logistics, Inc. as of August 2, 2021.
- [By ]
Breakups are a great way for companies to unlock a lot of value, Cramer reminded viewers. That's certainly been the case with XPO Logistics (XPO) – Get Report, which recently spun off GXO Logistics (GXO) – Get Report, and with the former L Brands, which split itself into Victoria's Secret (VSCO) – Get Report and Bath & Body Works (BBWI) – Get Report.
- [By Jeremy Bowman (TMFHobo)]
The transportation company just spun off its contract logistics division, GXO Logistics (NYSE:GXO), making it easier for investors to value the stock compared with less-than-truckload peers like Old Dominion and Saia. XPO also just posted record results in its second-quarter earnings report, showing the company is benefiting from the economic reopening.
Hot Heal Care Stocks To Invest In Right Now: Bayer Aktiengesellschaft (BAYRY)
Bayer AG is a life science company. The Company’s segments are Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment is engaged in the development of prescription pharmaceuticals; contraceptives, and medical products, such as injection systems and contrast agents for diagnostic procedures. The Consumer Health segment is engaged in the development of over-the-counter medications, dermatology products and nutritional supplements. The Crop Science segment is engaged in the development of product portfolio in the areas of seeds and plant traits, crop protection, home and garden, the green industry and nonagricultural pest control. The Animal Health segment is engaged in the development of veterinary medicines and animal grooming products. Covestro is engaged in the development of raw materials for polyurethanes; polycarbonate resins and sheets; raw materials for coatings, adhesives and sealants; and selected chemical intermediates.
- [By ]
Bayer (OTCPK:BAYRY) – Together with Orion Corporation, the company announced that the FDA accepted its New Drug Application and granted Priority Review for darolutamide for the treatment of non-metastatic castration-resistant prostate cancer in the United States. This decision was based on data from the phase III ARAMIS trial – recently, Bayer also submitted an application to the European Medicines Agency and the Ministry of Health, Labor and Welfare in Japan. The drug candidate is thought to have peak sales potential in excess of $1 billion.
- [By ]
Overall, investors need to rely on what is factual and can be referenced. FOTIVDA still outperforms Bayers (OTCPK:BAYRY) Nexavar in PFS and ORR. The preliminary OS data is not complete enough for the FDA and that should be acceptable for investors. In fact, the idea the company had not really addressed the issues from the previous CRL would have prevented me from entering a position prior to the PDUFA date. The market overreacted to the NDA delay news as if it was a CRL. Yes, the company has to hold off on submitting, but the management expects to file an NDA before the end of 2019; which would put the PDUFA date in the second half of 2020.
- [By Cory Renauer]
The first to earn approval, Vitrakvi, treats patients with any type of cancer, as long as their tumors test positive for a specific mutation. Bayer (NASDAQOTH:BAYRY) will market Vitrakvi and send Lilly royalties in a low-30s percentage range on U.S. sales and a tiered double-digit percentage of sales everywhere else.